Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.7080
-0.0300 (-4.07%)
At close: Dec 24, 2025, 1:00 PM EST
0.7003
-0.0077 (-1.09%)
After-hours: Dec 24, 2025, 4:23 PM EST
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $19.16 million as of December 24, 2025. Its market cap has decreased by -75.28% in one year.
Market Cap
19.16M
Enterprise Value
19.88M
1-Year Change
-75.28%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $19.16M, a decrease of -94.46%. That is a compound annual growth rate of -46.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 19.16M | -76.08% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |